EA201070334A1 - Пиперидиниламинотиено[2,3-d]пиримидиновые соединения для лечения фиброза - Google Patents

Пиперидиниламинотиено[2,3-d]пиримидиновые соединения для лечения фиброза

Info

Publication number
EA201070334A1
EA201070334A1 EA201070334A EA201070334A EA201070334A1 EA 201070334 A1 EA201070334 A1 EA 201070334A1 EA 201070334 A EA201070334 A EA 201070334A EA 201070334 A EA201070334 A EA 201070334A EA 201070334 A1 EA201070334 A1 EA 201070334A1
Authority
EA
Eurasian Patent Office
Prior art keywords
fibrosis
piperidinilaminotheno
treatment
pyrimidine compounds
modulator
Prior art date
Application number
EA201070334A
Other languages
English (en)
Inventor
Кимберли Ганнон
Филип Б. Грэхем
Original Assignee
ПиДжиэксХЭЛТ ЭлЭлСи
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ПиДжиэксХЭЛТ ЭлЭлСи filed Critical ПиДжиэксХЭЛТ ЭлЭлСи
Publication of EA201070334A1 publication Critical patent/EA201070334A1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Abstract

Изобретение относится к способу лечения или предупреждения фиброза у индивидуума введением модулятора 5-НТ, в частности 5-HT. В определенных вариантах осуществления модулятор 5-НТ представляет собой пиперидиниламинотиено[2,3-d]пиримидиновое соединение.
EA201070334A 2007-09-04 2008-09-04 Пиперидиниламинотиено[2,3-d]пиримидиновые соединения для лечения фиброза EA201070334A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US96982007P 2007-09-04 2007-09-04
PCT/US2008/075193 WO2009032885A2 (en) 2007-09-04 2008-09-04 Piperidinylamino-thieno[2,3-d] pyrimidine compounds for treating fibrosis

Publications (1)

Publication Number Publication Date
EA201070334A1 true EA201070334A1 (ru) 2010-10-29

Family

ID=40291329

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201070334A EA201070334A1 (ru) 2007-09-04 2008-09-04 Пиперидиниламинотиено[2,3-d]пиримидиновые соединения для лечения фиброза

Country Status (11)

Country Link
US (1) US20100280050A1 (ru)
EP (1) EP2194988A2 (ru)
JP (1) JP2010538078A (ru)
KR (1) KR20100072008A (ru)
CN (1) CN101820882A (ru)
AU (1) AU2008296308A1 (ru)
BR (1) BRPI0816464A2 (ru)
CA (1) CA2698377A1 (ru)
EA (1) EA201070334A1 (ru)
MX (1) MX2010002523A (ru)
WO (1) WO2009032885A2 (ru)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9271980B2 (en) * 2009-08-03 2016-03-01 Daljit Singh Dhanoa Deuterium-enriched pyrimidine compounds and derivatives
WO2016100940A1 (en) 2014-12-19 2016-06-23 The Broad Institute, Inc. Dopamine d2 receptor ligands
EP3233799B1 (en) 2014-12-19 2021-05-19 The Broad Institute, Inc. Dopamine d2 receptor ligands

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7030240B2 (en) * 2003-03-31 2006-04-18 Predix Pharmaceuticals Holdings, Inc. Piperidinylamino-thieno[2,3-d] pyrimidine compounds
US7612078B2 (en) * 2003-03-31 2009-11-03 Epix Delaware, Inc. Piperidinylamino-thieno[2,3-D] pyrimidine compounds
US20070213305A1 (en) * 2005-11-02 2007-09-13 Cytovia, Inc. N-alkyl-N-aryl-thienopyrimidin-4-amines and analogs as activators of caspases and inducers of apoptosis and the use thereof
US20080108611A1 (en) * 2006-01-19 2008-05-08 Battista Kathleen A Substituted thienopyrimidine kinase inhibitors

Also Published As

Publication number Publication date
BRPI0816464A2 (pt) 2015-03-24
EP2194988A2 (en) 2010-06-16
JP2010538078A (ja) 2010-12-09
WO2009032885A3 (en) 2009-04-30
CA2698377A1 (en) 2009-03-12
MX2010002523A (es) 2010-08-31
CN101820882A (zh) 2010-09-01
WO2009032885A2 (en) 2009-03-12
AU2008296308A1 (en) 2009-03-12
KR20100072008A (ko) 2010-06-29
US20100280050A1 (en) 2010-11-04

Similar Documents

Publication Publication Date Title
EA201001847A1 (ru) Соединения и композиции, применяемые для лечения малярии
TW200744586A (en) Therapeutic compounds
EA200870193A1 (ru) Цитотоксические агенты, включающие новые производные томаймицина, и их терапевтическое применение
TN2012000152A1 (en) Spiropiperidine compounds and pharmaceutical use thereof for treating diabetes
TW200626068A (en) Active compounds for seed treatment
ECSP11010980A (es) Compuestos heteroaromáticos espirocíclicos fusionados para el tratamiento de infecciones bacterianas
TW200626610A (en) Analogs of 17-hydroxywortmannin as PI3K inhibitors
MX2012003539A (es) Derivados de indol como moduladores de los canales de calcio activados por la liberacion de calcio (crac).
EA201200669A1 (ru) ПИРИДОПИРИМИДИНОНОВЫЕ ИНГИБИТОРЫ PI3Kα
RS52780B (en) MEANS OF PREVENTION AND TREATMENT OF DISORDERS CONCERNING MODULATION OF RYR RECEPTORS
DK1881967T3 (da) Substituerede benzo (D) isoaxol-3-yl-amin-forbindelser som analgetika
WO2009026166A3 (en) Antiinfective flavonol compounds and methods of use thereof
BR112012026767A2 (pt) composto, sal farmaceuticamente aceitável de um composto, composição farmacêutica, método para tratar ou previnir distúrbios, e, uso de um composto ou sal
EA200800760A1 (ru) ПИРИДОПИРИМИДИНОНОВЫЕ ИНГИБИТОРЫ PI3Kα
IS8505A (is) (S)-2-N-própýlamínó-5-hýdroxýetralín sem D3-gerandefni
NZ601350A (en) Method of treating arthritis
TN2012000248A1 (en) Novel spiropiperidine compounds
EA201170154A1 (ru) Производные пиридинопиридинонов, способ их получения и применение в терапии
TW200738651A (en) Cyclohexyl sulfonamide derivatives
MX2008013196A (es) 5-amido-2-carboxiamida-indoles.
MX2009005649A (es) Tratamiento para mieloma multiple.
EA200970936A1 (ru) СОЕДИНЕНИЯ ПИРИДО[2,3-d]ПИРИМИДИН-7-ОНА В КАЧЕСТВЕ ИНГИБИТОРОВ PI3K-АЛЬФА ДЛЯ ЛЕЧЕНИЯ РАКА
RS53613B1 (en) COMPOUNDS, COMPOSITIONS, AND PROCEDURES FOR TREATMENT OF BETA-AMYLOID DISEASES AND SYNUCLEINOPATHY
EA201170425A1 (ru) Тетрациклиновые соединения для лечения ревматоидного артрита и связанные с ними способы лечения
UA103500C2 (ru) Сульфоксиминзамещенные анилинопиримидиновые производные как cdk-ингибиторы, их получение и применение как лекарственных средств